Clinical trials: Chronic Disease of Cardiovascular System
Heart Failure, Copd
The DIVERT-CARE (Collaboration Action Research & Evaluation) Trial
Rationale: In Canada, home care clients are a large and expanding subgroup of medically complex older adults with relatively poor access to effective chronic disease management.
- Trial name
- DIVERT-CARE (NCT03012256)
- Testing
- Cardio-respiratory management model
- Where
- 3 sites in Canada
- Volunteers
- 896 people
- Sponsor
- McMaster University
Hypotension
Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients
Arterial hypotension is a frequent complication of general anesthesia and a significant contributor to postoperative complications.
- Trial name
- NORAFLOW (NCT06350929)
- Testing
- Cardiac output monitoring by the Starling™ SV Sebac®
- Where
- France
- Volunteers
- 50 people
- Sponsor
- University Hospital, Toulouse
Chronic Heart Failure
Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure
The renin-angiotensin system (RAS) is a regulatory system that plays an essential role in patients with chronic heart failure (CHF).
- Trial name
- VitD-CHF (NCT01092130)
- Testing
- Vitamin D
- Where
- Netherlands
- Volunteers
- 101 people
- Sponsor
- University Medical Center Groningen
Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
This randomized phase II trial studies how well giving tacrolimus and mycophenolate mofetil (MMF) with or without sirolimus works in preventing acute graft-versus-host disease (GVHD) in patients undergoing donor stem cell…
- Conditions
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic Lymphocytic Leukemia, Refractory Plasma Cell Myeloma
- Trial name
- NCT00105001
- Testing
- Fludarabine Phosphate, Total-Body Irradiation, Peripheral Blood Stem Cell Transplantation
- Where
- 11 sites in United States, Denmark and 1 more
- Volunteers
- 210 people
- Sponsor
- Fred Hutchinson Cancer Center
Acute Leukemia, Multiple Myeloma
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
This is a multicenter, experimental preclinical study conducted on primary samples from patients diagnosed with hematological or solid neoplasms defined as high risk.
- Conditions
- Acute Leukemia, Multiple Myeloma, Squamous Cell Carcinoma, Pleural Mesothelioma
- Trial name
- IT-TCP POS (NCT07403630)
- Testing
- Functional tests, Multi-omics analyses, Cytogenetics/ FISH
- Where
- 2 sites in Italy
- Volunteers
- 300 people
- Sponsor
- Azienda Ospedaliero-Universitaria di Parma
End Stage Renal Disease, Arteriovenous Fistula
Trial of Fistula Versus Graft in Elderly Patients
This open-label pilot randomized controlled trial will test the feasibility and safety of randomizing patients over 65 years old who start hemodialysis with a tunneled dialysis catheter (TDC), and are eligible to receive either…
- Conditions
- End Stage Renal Disease, Arteriovenous Fistula, Arteriovenous Graft
- Trial name
- NCT03668002
- Testing
- Arteriovenous Fistula (AVF), Arteriovenous Graft (AVG)
- Where
- United States
- Volunteers
- 21 people
- Sponsor
- University of Pittsburgh
Subdural Hematoma
Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma
The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the Onyx™ Liquid Embolic System (LES) for treatment of symptomatic subacute or chronic subdural hematoma…
- Trial name
- EMBOLISE (NCT04402632)
- Testing
- Surgical Management, Onyx™ Liquid Embolic System (LES) Embolization, Observation Only
- Where
- 49 sites in United States
- Volunteers
- 600 people
- Sponsor
- Medtronic Neurovascular Clinical Affairs
Chronic Kidney Disease, Cardiovascular Disease
Pomegranate Supplementation on Physical Function and Cardiovascular Disease Risk in CKD Patients
Chronic kidney disease (CKD) patients have very low physical function and high rates of cardiovascular disease (CVD) mortality. The objective of the proposed research is to evaluate the effects of dietary supplementation with a…
- Trial name
- NCT01324193
- Testing
- Pomegranate extracts
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- Kenneth Wilund
Stroke, Ischemic
The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools
Cerebral infarction is the second cause of death and the third cause of disability. More than 13.7 million patients worldwide are diagnosed with stroke every year, and the number of deaths is 5.5 million, of which ischemic stroke…
- Trial name
- NCT06342206
- Where
- Taiwan
- Volunteers
- 24 people
- Sponsor
- China Medical University Hospital
Pulmonary Disease, Chronic Obstructive
Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists
Examine the risk of cardiovascular events (cardiac arrhythmia or myocardial ischemia) or all-cause mortality in Chronic Obstructive Pulmonary Disease (COPD) patients who are new users of Olodaterol or other LABAs available for…
- Trial name
- NCT03405363
- Where
- Denmark
- Volunteers
- 65,406 people
- Sponsor
- Boehringer Ingelheim
Chronic Patients, Heart Failure
Multicenter Trial for the Validation of Vitalera Platform
Vitalera has implemented a cloud platform for the telemonitoring of chronic patients through portable medical devices and an alarm-based system that issues health alerts when a patient's biomedical measurement is outside a…
- Trial name
- VAL-HIC (NCT05825755)
- Testing
- vitalera telemonitoring platform
- Where
- 10 sites in Spain
- Volunteers
- 97 people
- Sponsor
- humanITcare
Stroke
Constraint-Induced Movement Therapy in Chronic Stroke Patients
The aim of this study is to evaluate the feasibility of a Home-based Constraint-Induced Movement Therapy (hCIMT) compared to a Modified Constraint-Induced Movement Therapy (mCIMT) delivered in a outpatient setting on upper limb…
- Trial name
- NCT02345525
- Testing
- mCIMT, hCIMT
- Where
- Italy
- Volunteers
- 20 people
- Sponsor
- University Hospital of Ferrara
Stroke
Sit-to-stand Training With Interactive Feedback in Chronic Stroke
The major problems of people with chronic stroke include muscle weakness, sensory alteration, and inter-muscular coordination impairment.
- Trial name
- NCT05945134
- Testing
- Visual and auditory feedback STS training, Conventional STS training
- Where
- Taiwan
- Volunteers
- 20 people
- Sponsor
- National Yang Ming Chiao Tung University
Hypertension, Dyslipidemias
Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels
This study investigates the causal relationships between antihypertensive and lipid-lowering drugs and inflammatory cytokines using a drug-targeted Mendelian randomization approach.
- Conditions
- Hypertension, Dyslipidemias, Inflammatory Response, Chronic Inflammation
- Trial name
- MRDLT (NCT06622304)
- Where
- China
- Volunteers
- 250,736 people
- Sponsor
- Guangzhou Institute of Respiratory Disease
Chronic Stroke
tDCS and Metacognitive Strategy Training in Stroke
Specific Aim 1: Complete pilot testing of study protocol in individuals with chronic stroke for feasibility evaluation and protocol refinement.
- Trial name
- NCT05248178
- Testing
- CO-OP Procedures, tDCS, Computer Cognitive Training Procedures
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- University of Missouri-Columbia
Congestive Heart Failure
Extracorporeal Shockwave Myocardial Revascularization (ESMR) Therapy For The Treatment of Chronic Heart Failure
Evaluation of non-invasive treatment modality, using low-intensity extracorporeal shockwaves for treatment of subjects diagnosed with Congestive Heart Failure, with ischemic etiology.
- Trial name
- NCT01251185
- Testing
- Cardiospec
- Where
- Israel
- Volunteers
- 9 people
- Sponsor
- Medispec
CKDu, Arterial Stiffness
An Investigation Into the Cardiovascular Risk and Aetiology of CKDu in Sri Lanka
1. We hypothesise that CKDu patients will have increased arterial stiffness and thus increased all-cause and cardiovascular mortality.
- Conditions
- CKDu, Arterial Stiffness, Proteinuria, Serum Creatinine
- Trial name
- NCT02226055
- Testing
- Arterial Stiffness Assessment
- Where
- Sri Lanka
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- University of Edinburgh
Stroke, Ischemic, Acute Pain
Effects of Mirror Therapy Versus Fine Motor Activities on Hand Function in Chronic Stroke Patients.
to compare the effects of the Mirror therapy and fine motor activities on hand function in chronic stroke patients
- Conditions
- Stroke, Ischemic, Acute Pain, Weakness, Muscle
- Trial name
- NCT05506826
- Testing
- fine motor activities, conventional therapy and mirror therapy
- Where
- Pakistan
- Volunteers
- 28 people
- Sponsor
- Riphah International University
Stroke
Exercise the Mind and Brain. A Multimodal Intervention in Stroke
The main objective of MindFit Project is to develop an evidence-based multimodal investigation of combined non-pharmacological strategies in chronic stroke patients and clarify the neuroplasticity mechanisms underlying the…
- Trial name
- Mindfit (NCT04759950)
- Testing
- Multicomponent Physical Activity Program, Mindfulness-Based Stress Reduction Program, Computerized Cognitive Training
- Where
- Spain
- Volunteers
- 141 people
- Sponsor
- University of Barcelona
Drug/Agent Toxicity by Tissue/Organ, Leukemia
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
RATIONALE: Keratinocyte growth factor may prevent symptoms of mucositis in patients receiving radiation therapy and chemotherapy.
- Conditions
- Drug/Agent Toxicity by Tissue/Organ, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
- Trial name
- NCT00004132
- Testing
- filgrastim, palifermin, cyclophosphamide
- Where
- United States
- Sponsor
- Jonsson Comprehensive Cancer Center
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.